Data from MHRA (Medicines and Healthcare products Regulatory Agency, UK) - Curated by EPG Health - Last updated 28 February 2018
Indication(s)
Learning Zones
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
Allergic Rhinitis
Allergic rhinitis causes great strain on the workforce. Help to reduce sick days and improve productivity with appropriate treatment options.
+ 4 more
Chronic Spontaneous Urticaria (CSU)
Use our patient case studies to discover how experts diagnose and treat chronic spontaneous urticaria.
+ 7 more
Chronic Obstructive Pulmonary Disease (COPD)
View highlights from recent congresses presented in new expert videos with leading physicians.
+ 7 more
Atopic Dermatitis
The Atopic Dermatitis Knowledge Centre is an educational resource, intended for healthcare professionals, that provides credible medical information on the epidemiology, pathophysiology and burden of atopic dermatitis, as well as diagnostic techniques, treatment regimens and guideline recommendations.
EADV 2018 Highlights
EADV Congress 2018: Bringing you the latest news and insights from 27th EADV Congress, 12-16 September 2018 Paris, France.
Acute and Advanced Heart Failure
What are the most effective treatments for acute heart failure? Can you define advanced heart failure? Discover here...
+ 3 more
Migraine Knowledge Centre
The Migraine Knowledge Centre features latest research on the prevalence and impact of migraine, the proposed neurological basis of the condition (and how this is being translated into new and exciting drug therapies), as well as current patient care strategies collated from headache organisations worldwide.
Inflammatory bowel disease assessment tools
'New IBD assessment tools at a glance' - an educational symposium sponsored by Sandoz.
Related Content
OPTIMA: Efficacy of Optimized Re-treatment and Step-up Therapy With Omalizumab in Chronic Spontaneous Urticaria (CSU) Patients (OPTIMA)
This trial will assess the efficacy of optimized re-treatment therapy with omalizumab (150mg or 300mg) after relapse, in patients with Chronic Spontaneous Urticaria who were clinically well-controlled...
Added 1 year ago
Compliance and Usability Study Evaluating RHINIX™ Nasal Filters
This study will investigate usability and compliance related to rhinix nasal filters for the treatment of seasonal allergic rhinitis (hay...
Added 5 years ago
A prospective, randomized, open, multi-centre study to assess safety of PURETHAL Birch given with a rush up-dosing regimen to patients with allergic rhinitis/rhinoconjunctivitis.
The aim of the study is to show that reaching the maintenance dose of 0.5 ml PURETHAL Birch following a...
Added 6 years ago
A multi-centre, double-blind dose-ranging study to evaluate the efficacy and safety/tolerability of Birch Modified Allergen Tyrosine-adsorbed + MPL (POLLINEX Quattro® Birch) in Subjects with seasonal allergic rhinoconjunctivitis due to birch pollen
The primary objective is to assess the difference in change (baseline to post-treatment) in total symptom score (TSS) recorded following...
Added 6 years ago
Effect of Intralymphatic Immunotherapy on Basophil Response and Plasma Cell Kinetics in Allergic Patients
We would like to evaluate the effect of Intralymphatic Immunotherpy (ILIT) on patients with rhinoconjunctivitis due to grass pollen allergy. 1....
Added 6 years ago
The impact of asthma, chronic bronchitis and allergic rhinitis on all-cause hospitalizations and limitations in daily activities: a population-based observational study.
Chronic respiratory diseases are a significant cause of morbidity and mortality worldwide. We sought to evaluate the impact of asthma, chronic bronchitis and allergic rhinitis on all-cause hospitalizations...
Added 1 year ago
Keys to successful management of patients with allergic rhinitis: Focus on patient confidence, compliance and satisfaction.
The American Academy of Otolaryngic Allergy (AAOA) convened an expert, multidisciplinary Working Group on Allergic Rhinitis to discuss patients' self-treatment behaviors and how health care providers approach and treat the condition.
Added 1 year ago
Efficacy and patient satisfaction with cromolyn sodium nasal solution in the treatment of seasonal allergic rhinitis: a placebo-controlled study
Because the symptoms of seasonal allergic rhinitis are readily recognizable, many individuals self-medicate with nonprescription agents.
Added 1 year ago
Burden of concomitant allergic rhinitis in adults with asthma
Asthma (A) and allergic rhinitis (AR) are common conditions with evidence of shared epidemiological and patho-physiological backgrounds.
Added 1 year ago
Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms
Few studies have directly compared the efficacy of intranasal corticosteroids with that of leukotriene receptor antagonists for the treatment of daytime and nighttime symptoms of seasonal allergic rhinitis (SAR).
Added 1 year ago
Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases
The present guideline was developed on behalf of and financed by the German Society for Allergology and Clinical Immu-nology (Deutsche Gesellschaft für Allergologie und klinische Immunologie, DGAKI)...
Added 1 year ago
BSACI guidelines: Immunotherapy for allergic rhinitis
Allergic rhinitis (AR) affects more than 20% of the population in the United Kingdom and western Europe and represents a major cause of morbidity that includes interference with usual daily activities and impairment of sleep quality.
Added 7 years ago
BSACI guidelines for the management of allergic and non-allergic rhinitis
This is an updated guideline for the diagnosis and management of allergic and non-allergic rhinitis, first published in 2007.
Added 11 years ago
More information
Category | Value |
---|---|
Authorisation number | PL 15142/0258 |
Orphan designation | No |
Date First Approved | 01-01-2013 |
Date Last Revised | 01-09-2015 |
Type | Medicinal product subject to medical prescription |
Marketing authorisation holder | Meda Pharmaceuticals Ltd |